Bank of New Hampshire’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-326
Closed -$9.15K 565
2026
Q1
$9.15K Sell
326
-49
-13% -$1.3K ﹤0.01% 463
2025
Q4
$9.34K Sell
375
-75
-17% -$1.89K ﹤0.01% 412
2025
Q3
$11.5K Hold
450
﹤0.01% 395
2025
Q2
$10.9K Sell
450
-221
-33% -$5.15K ﹤0.01% 399
2025
Q1
$17K Sell
671
-453
-40% -$11.9K ﹤0.01% 367
2024
Q4
$29.8K Sell
1,124
-142
-11% -$3.85K 0.01% 323
2024
Q3
$36.6K Sell
1,266
-915
-42% -$26.7K 0.01% 315
2024
Q2
$61K Sell
2,181
-4,240
-66% -$117K 0.02% 299
2024
Q1
$178K Sell
6,421
-556
-8% -$15.4K 0.05% 202
2023
Q4
$201K Sell
6,977
-5,284
-43% -$160K 0.06% 187
2023
Q3
$407K Sell
12,261
-160
-1% -$5.66K 0.12% 142
2023
Q2
$456K Sell
12,421
-1,810
-13% -$70.5K 0.13% 138
2023
Q1
$581K Sell
14,231
-545
-4% -$23.5K 0.17% 122
2022
Q4
$757K Sell
14,776
-1,325
-8% -$63.5K 0.23% 105
2022
Q3
$705K Buy
16,101
+167
+1% +$8.12K 0.22% 110
2022
Q2
$835K Sell
15,934
-25
-0.2% -$1.27K 0.24% 103
2022
Q1
$826K Buy
15,959
+185
+1% +$9.6K 0.2% 118
2021
Q4
$931K Sell
15,774
-2,317
-13% -$115K 0.23% 113
2021
Q3
$708K Hold
18,091
0.19% 121
2021
Q2
$708K Buy
+18,091
New +$704K 0.19% 121

Other funds holding PFE

Bank of New Hampshire's PFE Position: Q2 2026 in Review

Bank of New Hampshire sold out of Pfizer (PFE) in Q2 2026, closing a stake of 326 shares — an estimated $9.15K sold.

Bank of New Hampshire first reported a position in PFE in Q2 2021 and held it in 20 quarters. The position peaked at $931K in Q4 2021. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bank of New Hampshire reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Bank of New Hampshire sold 326 Pfizer shares in Q2 2026, an estimated $9.15K.
  • Bank of New Hampshire first reported a position in Pfizer in Q2 2021 and held it in 20 quarters.
  • Bank of New Hampshire's Pfizer position peaked at $931K in Q4 2021.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.